glp-1 drugs covered by medicare cuts cost of popular weight-loss for eligible seniors New Medicare GLP-1 Bridge Program
Description
Primary care-based investigation of the effect of sitagliptin on blood pressure in hypertensive patients with type 2 diabetes
While more research is needed, these findings suggest a promising avenue for those with chronic conditions
Despite new insulin formulations and improvements in the technology of insulin pumps and continuous glucose monitoring, glycemic control continues to be suboptimal in T1D, with about 80% of patients not reaching the recommended goals
Curr Diab Rep
Additionally, the presence of emerging pharmaceutical companies and increased foreign direct investments contributes to market dynamism
